Organization: Health Canada
Year: 2023
Month: February
Request Number: A-2022-001140
Request Summary: Adverse Drug Reaction (ADR) for MEZAVANT. Report number: 001010016. ADRs for MESALAZINE. Report numbers: E2B_05749207, E2B_05793049, 001010704, 001010568, 001014435, 001010569, 001013512, 001015438. ADR for MESALAMINE. Report number: E2B_05759898.
Disposition: Disclosed in part
Number of pages: 68